Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Michael Marks 
;
Sarah Gwyn;
Hilary Toloka;
Christian Kositz ;
James Asugeni;
Rowena Asugeni;
Jason Diau;
John M Kaldor;
Lucia Romani;
Michelle Redman-MacLaren;
+5 more...
David MacLaren;
Anthony W Solomon;
David CW Mabey ;
Andrew C Steer;
Diana Martin;
(2020)
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (12).
pp. 3226-3228.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa584
;
Sarah Gwyn;
Hilary Toloka;
Christian Kositz ;
James Asugeni;
Rowena Asugeni;
Jason Diau;
John M Kaldor;
Lucia Romani;
Michelle Redman-MacLaren;
+5 more...
David MacLaren;
Anthony W Solomon;
David CW Mabey ;
Andrew C Steer;
Diana Martin;
(2020)
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (12).
pp. 3226-3228.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa584
The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.
-
picture_as_pdf - ciaa584.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads